A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body
Clinical trial NCT03955939 · COMPLETED
Trial details
- NCT number
- NCT03955939
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-02
- Primary completion
- 2020-05-14
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.